Copyright
©The Author(s) 2021.
World J Hepatol. Jan 27, 2021; 13(1): 151-161
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.151
Published online Jan 27, 2021. doi: 10.4254/wjh.v13.i1.151
Ref. | Number of cases | Technique | Venovenous bypass use | Outcomes |
Yan et al[14], 2006 | n = 1 | IVC replacement with cadaveric IVC allograft | Yes | Alive after 3 mo |
Yamada et al[2], 2006 | n = 1 | IVC resection without replacement | No | Alive after 10 mo |
Shimoda et al[15], 2007 | n = 1 | IVC replacement with autologous internal jugular vein, external iliac vein and suprarenal IVC | No | Alive after 17 mo |
Sasaki et al[16], 2009 | n = 1 | IVC replacement with cadaveric IVC allograft | No | N/A |
Kazimi et al[32], 2009 | n = 1 | IVC resection without replacement | No | Alive after 3 mo |
Choi et al[3], 2010 | n = 2 | IVC replacement with cadaveric IVC allograft (n = 1) and RHV-atrial shunt using preexisting mesoatrial shunt (n = 1) | No | Both alive after a median follow-up of 18 mo |
Ogura et al[21], 2011 | n = 1 | IVC replacement with an inverted composite graft (Gore-Tex stretch vascular graft and transposed IVC) | Yes | Alive after 24 mo |
Sakçak et al[19], 2012 | n = 1 | IVC replacement with cadaveric aortic allografts | No | Alive after 4 mo |
Fukuda et al[24], 2013 | n = 1 | IVC resection without replacement | No | Alive after 60 mo |
Yagci et al[17], 2015 | n = 4 | IVC replacement with cadaveric IVC (n = 1), iliac vein (n = 1) and aorta allografts (n = 2) | No | 2 patients died due to biliary complications after 5 mo of follow-up |
Cetinkunar et al[20], 2015 | n = 1 | IVC replacement by cadaveric aortic allograft | No | Alive after 4 mo |
Ara et al[7], 2016 | n = 7 | IVC replacement with cadaveric IVC (n = 4) and cadaveric aorta allografts (n = 2). No replacement in one case | No | 2 patients died due to recent HAT after LT, and 2 patients died of sepsis during follow-up |
Pahari et al[12], 2016 | n = 2 | IVC replacement with e-PTFE graft | No | Both alive after a median follow-up of 18 mo |
Karaca et al[6], 2017 | n = 3 | IVC resection without replacement | No | N/A |
Sabra et al[25], 2018 | n = 1 | IVC resection without replacement | No | Alive after 3 mo |
Yagi et al[22], 2018 | n = 1 | IVC replacement with an inverted composite graft (e-PTFE graft and transposed IVC) | Yes | Alive after 36 mo |
Ionescu et al[23], 2018 | n = 2 | IVC replacement with caval-dacron composite graft | No | Both alive (follow-up not available) |
Yoon et al[13], 2019 | n = 5 | IVC replacement with synthetic material (ringed polyester) | Yes (n=3) | All alive after a median follow-up of 10.5 years |
Gonultas et al[18], 2020 | n = 12 | IVC replacement with cadaveric IVC allograft (n = 6), cadaveric aorta allograft (n = 1), synthetic material (n = 3, Dacron) and caval-dacron composite graft (n = 2) | No | All alive after median follow-up of 15 mo |
Present study | n = 1 | IVC replacement with cadaveric IVC allograft | Yes | Alive after 25 mo |
- Citation: Rocha-Santos V, Waisberg DR, Pinheiro RS, Nacif LS, Arantes RM, Ducatti L, Martino RB, Haddad LB, Galvao FH, Andraus W, Carneiro-D'Alburquerque LA. Living-donor liver transplantation in Budd-Chiari syndrome with inferior vena cava complete thrombosis: A case report and review of the literature. World J Hepatol 2021; 13(1): 151-161
- URL: https://www.wjgnet.com/1948-5182/full/v13/i1/151.htm
- DOI: https://dx.doi.org/10.4254/wjh.v13.i1.151